At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 357 enrolled
Drug / intervention
bimatoprost solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bimatoprost for the Treatment of Eyebrow Hypotrichosis
In Brief
A Phase 3 clinical trial evaluating bimatoprost solution and Vehicle to bimatoprost solution for Eyebrow Hypotrichosis. Completed, enrolled 357 participants across 2 sites in 2 countries.
Detailed Summary
This study will evaluate the safety and efficacy of bimatoprost solution compared with vehicle in the treatment of eyebrow hypotrichosis (inadequate eyebrows).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEyebrow Hypotrichosis
CountriesCanada, United States
Collaborators--
Timeline
Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 2013
Enrollment StartMar 2013
Primary CompletionJan 2014
Study CompletionFeb 2014
TodayJul 2026
First PostedJan 10, 2013
Enrollment StartMar 13, 2013
Primary CompletionJan 31, 2014
Study CompletionFeb 11, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.5 years ago
Interventions
bimatoprost solutiondrug
Bimatoprost solution once a day or twice a day applied to each eyebrow for 7 months.
Vehicle to bimatoprost solutiondrug
Vehicle to bimatoprost solution once or twice a day applied to each eyebrow for 7 months.